Paediatric oncology providers' perspectives on early integration of paediatric palliative care

Rima Saad1, Lina Badr Kurdahi2, Nuhad Yazbick-Dumit3

  • 1Clinical Nurse Specialist, Children's Cancer Institute, American University of Beirut Medical Center, Lebanon.

Insights

Healthcare providers view paediatric palliative care (PPC) as end-of-life support, impacting its early integration. Effective PPC requires interdisciplinary collaboration and improved communication with children and families.

Area of Science:

  • Pediatric Oncology
  • Palliative Care
  • Healthcare Provider Perceptions

Background:

  • Healthcare providers' perceptions of palliative care significantly influence its early integration in pediatric cancer management.
  • Understanding these perspectives is crucial for informed decision-making in pediatric palliative care (PPC).

Purpose of the Study:

  • To explore the perceptions of pediatric oncology providers regarding the integration of early PPC.
  • Focus on providers at the Children's Cancer Institute (CCI) in Lebanon.

Main Methods:

  • Qualitative descriptive research design.
  • Focus groups conducted in a leading pediatric oncology setting.

Main Results:

  • Providers perceived PPC primarily as end-of-life pain relief and psychological support.
  • Integration timing was linked to end-of-life, advanced disease, or treatment failure.
  • Interdisciplinary collaboration and communication with patients/families were identified as critical but challenging aspects.

Conclusions:

  • The study highlights healthcare providers' perceptions of early PPC in pediatric oncology in Lebanon.
  • Emphasizes the importance of interdisciplinary collaboration and effective communication for optimal PPC management.
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
176
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
134
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K